Category: Blood

<!– Troy Church of the Brethren blood drive set Oct. 25 – Miami Valley Today

SOUTHERN TIER, N.Y. (WETM) — The American Red Cross will be hosting more than a dozen blood drives across the Southern Tier over the next month to help address the national blood shortage. According to the Red Cross, thousands of people donated blood and platelets to help with the shortage last month, but at least 10,000 more donations are needed each week over the next month to meet hospital needs. The Red Cross is urging eligible donors, particularly those with type O blood and those giving platelets, to attend one of its blood drives. The Red Cross is offering people who donate blood or platelets from Oct. 21 through Nov. 9 a $10 gift card to a restaurant of their choosing to encourage more donations. Donors will also be entered to win one of three $5,000 gift cards. Details about this promotion can be found on the Red Cross’s website. Red Cross declares national blood shortage ‘in wake of back-to-back climate disasters’ Getting a flu or COVID-19 vaccine does not affect blood donor eligibility. As long as a potential donor feels healthy on their donation day and meets other donor requirements (including weighing at least 110 pounds and being over the age of 17 or 16 with written parental permission) and brings proper identification, they can donate. A full list of donation eligibility requirements can be found on the Red Cross’s website. Those interested in donating blood can make an appointment for one of the upcoming drives being held in the Southern Tier. A list of blood drives scheduled between Oct. 21 and Nov. 9 broken down by location can be found below: Chemung County Elmira First Presbyterian Church Oct. 26 from 1 p.m. to 6 p.m. 1054 West Clinton Street North Presbyterian Church Nov. 2 from 12 p.m. to 4 p.m. 921 College Avenue Big Flats Arnot Mall Oct. 21 from 10 a.m. to 2 p.m. 3300 Chambers Road Horseheads American Legion Post 442 Oct. 25 from 12:30 p.m. to 5:30 p.m. 71 Old Ithaca Road Horseheads Fire Department Oct. 31 from 2 p.m. to 7 p.m. 134 North Main Street Schuyler County Montour Falls Schuyler County Humane Services Nov. 11 from 9:30 a.m. to 2:30 p.m. 323 Owego Street Watkins Glen KOA Watkins Glen Oct. 21 from 10 a.m. to 3 p.m. 1710 state Route 414 Why blood donations are needed year-round Steuben County Addison Addison Central School Oct. 31 from 9:30 a.m. to 2:30 p.m. 1 Colwell Street Addison Community Center Nov. 4 from 8 a.m. to 12 p.m. 13 Community Drive, Suite 103 Avoca Howard Community Center Oct. 31 from 1 p.m. to 6 p.m. 7481 Hopkins Road Bath Lakeview Apartments Oct. 24 from 1 p.m. to 6 p.m. 105 Geneva Street Centenary United Methodist Church Nov. 1 from 11:30 a.m. to 5:30 p.m. 3 West Washington Street Taylor Health at Ira Davenport Memorial Hospital Nov. 3 from 9 a.m. to 1 p.m. 7571 state Route 54 Campbell Campbell Savona High School Oct. 25 from 12 p.m. to 6 p.m. 8455 county Route 125 Corning VFW Post 524 Oct. 23 from 12 p.m. to 5 p.m. 281 Baker Street Southeast Steuben County Library Nov. 9 from 12:30 p.m. to 5 p.m. 300 Nasser Civic Center Plaza, Suite 101 Painted Post Forest View-Gang Mills Fire Department Oct. 28 from 10 a.m. to 3 p.m. 125 Forest Drive United Church of Painted Post Nov. 1 from 11:30 a.m. to 4:30 p.m. 201 North Hamilton Street Victory Highway Wesleyan Church Nov. 9 from 12:30 p.m. to 4:30 p.m. 150 Victory Highway

Erie News Now: Coverage You Can Count On #PageTitle8910790 a:link{color: ;text-decoration: ;} #PageTitle8910790 a:visited{color: ;text-decoration: ;} #PageTitle8910790 a:hover{color: ;text-decoration: ;} #PageTitle8910790 a:active{color: ;text-decoration: ;}

An IIT Bombay incubated company, ImmunoACT, has been granted approval by Indian drug regulator Central Drugs Standard Control Organization (CDSCO) for its CAR-T cell therapy NexCAR19. According to an ET report, this therapy, which is backed by drug maker Laurus Labs, is designed to treat certain types of blood cancers. NexCAR19 is the first humanized CD19-targeted Chimeric Antigen Receptor T cell (CAR-T) therapy developed in India to receive approval.The therapy will be used for the treatment of relapsed/refractory (r/r) B-cell lymphomas and leukemia in India. Although the pricing of NexCAR19 has not been disclosed, ImmunoACT has stated that it aims to make the therapy available to its partner hospitals as soon as possible. In the past, ImmunoACT’s CEO, Rahul Purwar, announced that the CAR-T cell therapy would be priced between Rs 30 lakh and Rs 40 lakh per patient, significantly cheaper than existing treatments, which cost 3-4 crore (INR) per patient.The approval was based on the results of a multi-center phase I/II pivotal clinical trial led by Dr. Hasmukh Jain. The trial involved 60 patients with relapsed/refractory B-cell lymphomas and leukemia. The clinical data showed an overall response rate (ORR) of 70%. Additionally, the therapy demonstrated a favorable safety profile, with low toxicity and minimal side effects such as cytokine release syndrome (CRS). This indicates a significant improvement over other commercially approved CD19-directed CAR-T cell therapies, the report said. Union Minister Piyush Goyal advocates strengthening consumer and data protection laws for startups NexCAR19 is the result of a decade-long collaboration between IIT-Bombay and Tata Memorial Centre (TMC). The design and development of NexCAR19 were led by Atharva Karulkar, Alka Dwivedi, and a team headed by Rahul Purwar, associate professor at IIT Bombay. The therapy underwent integrative process development and manufacturing under cGMP at ImmunoACT. Clinical investigations and translational studies were conducted by Dr. Hasmukh Jain, Dr. Gaurav Narula, and their teams at Tata Memorial Hospitals.Rahul Purwar, Founder and CEO of ImmunoACT, said, “Now our patients in India and countries with limited resources will have access to this life-saving drug at an affordable cost.” He also emphasized the significance of this achievement, comparing it to a “moon shot” and highlighting that it positions India among a select group of countries with access to CAR-T therapy.Hyderabad-based drug maker Laurus Labs has been a key supporter of ImmunoACT, investing over $18 million to help scale its research and development efforts, as well as its commercialization endeavors.

Shocking footage shows pet dog refusing to leave bed where Hamas butchered children in blood-stained and bullet-riddled house where terrorists slaughtered entire family By Chloe Louise Published: 10:34 EDT, 14 October 2023 | Updated: 11:06 EDT, 14 October 2023

LAS VEGAS (KSNV) — The American Red Cross of Southern Nevada is urging community members to take two crucial steps this season—get vaccinated against the flu and donate blood. Officials said getting the flu shot and COVID-19 booster could be more important than ever as a severe flu season and possible overlapping COVID-19 resurgence might add to the current challenges that have led to a blood shortage. “We know many folks are getting their flu shots this year and are wondering if they can still donate blood after being vaccinated, whether it’s the flu shot, COVID-19 booster, or the new RSV vaccine,” said Dr. Walter Kelley, Medical Director for the Rocky Mountain Division of the American Red Cross. “Let’s clear this up. Yes, you absolutely can. There’s no need to wait after getting vaccinated to donate blood.” READ MORE NEWS 3 | The Animal Foundation seeking donations for dog found suffering from gunshot wound This year has seen thousands of potential blood donations uncollected as severe weather events forced the closure of blood donation centers and the cancellation of blood drives across the country. According to officials, the last time the Red Cross declared a national blood emergency was in January 2022, which was the worst blood shortage in over a decade. Hospital demand for blood currently exceeds the rate of incoming donations, causing a 25% decrease in the Red Cross national blood supply. While all blood types are needed, there is a critical need for type O donors. Type O positive is the most frequently transfused blood type, while O negative serves as the universal donor and is often used in emergencies when the patient’s blood type cannot be quickly determined. Donors can schedule an appointment using the Red Cross Blood Donor App by visiting redcrossblood.org or calling 1-800-RED CROSS (1-800-733-2767).

A Rensselaer County man has died — two days after he was arrested for allegedly driving with a blood alcohol level nearly five times the legal limit. Thomas R. Murphy, 45, of Wynantskill, was arrested after a traffic stop on Oct. 9 at about 2 a.m. in Sand Lake. Troopers responded to a report of a car off the roadway at the intersection of Miller Road and Snake Hill Road. Murphy denied he was injured and was charged with DWI and other traffic violations. He was transported to the State Police station in Sand Lake, where he recorded a 0.38% blood alcohol concentration. The legal limit for intoxication is 0.08%. Murphy was issued tickets to appear at a later date and released to a sober third party. Update: Murphy died on Oct. 11, according to Legacy.com.

GENEVA — Geneva General Hospital will host an American Red Cross blood drive from 10 a.m. to 3 p.m. Oct. 26 in Conference Room A/B on the basement level of the 196 North St. facility. The Red Cross is facing a national blood crisis, its worst blood shortage in over a decade, posing a concerning risk to patient care. Blood and platelet donations are critically needed to help prevent further delays in vital medical treatments. To schedule an appointment, contact Alicia at [email protected] or visit redcrossblood.org and enter keyword GENEVAHOSPITAL. Those interested also can call 1-800-RED CROSS (1-800-733-2767).

‘Full fat’ sugary drinks such as colas increase the risk of obesity and are generally off-limits for diabetics. But now a leading testing expert says there is increasing evidence that many diet drinks containing artificial sweeteners affect blood sugar levels, insulin resistance and our gut microbiome. It’s well-known that ‘full fat’ fizzy drinks such as colas, lemonades and energy drinks raise the risk of obesity, heart disease and diabetes. People who have one can or more a day have a 26% increased risk of developing type 2 diabetes. Sugary drinks rapidly increase blood sugar levels and this can lead to tiredness and increased hunger even in people without diabetes. Until now, their sugar-free diet equivalents have been regarded as the healthier alternative. While sugary drinks are generally off-limits for Britain’s 4.3 million registered diabetics (except in emergencies when their blood sugar levels need to rise rapidly), it’s not been thought that diet drinks pose a risk for diabetics or anyone trying to lose weight. However, a leading medical expert says there is now strong evidence that many types of artificial sweeteners used in diet drinks (and some foods) affect our blood sugar levels, worsen insulin resistance and alter our gut flora. Dr Avinash Hari Narayanan (MBChB), Clinical Lead at London Medical Laboratory, says: ‘The fact that many so-called “diet” drinks could be exacerbating symptoms for known diabetics, as well as severely affecting those who remain undiagnosed, is bad news. ‘London Medical Laboratory’s latest analysis reveals one million people in the UK are likely to have undiagnosed type 2 diabetes. This invisible killer shortens lives by up to ten years. That’s why we launched our “Give the finger to diabetes” campaign to identify undiagnosed cases with a simple fingerprick blood test. In 2019, there were almost 14,000 diabetes-related deaths in the UK. The earlier people are diagnosed, the better the outcome. ‘Increasingly, diabetics and health-conscious people have turned to sugar-free versions of their favourite drinks. However, our analysis of the latest research finds that saccharin and sucralose are likely to increase blood sugar or glucose levels and adversely impact the gut microbiome (the collection of organisms that live in our digestive tracts). Researchers at John Hopkins University recently tested random groups of healthy, non-diabetic people and found that participants taking saccharin and sucralose had noticeable spikes in their blood sugar levels. ‘The researchers discovered that these sweeteners were influencing changes in bacteria in the gut and mouth. Changes were also identified in their blood samples. In fact, the blood metabolite changes in those people consuming saccharin and sucralose were so marked they were similar to those in people with diabetes or vascular diseases. Related Stories ‘The researchers concluded that “some commonly consumed non-nutritive sweeteners may not be physiologically inert in humans as previously contemplated.” Gut microbiome changes can cause spikes in blood glucose, impairing the body’s ability to effectively regulate glucose levels. ‘This finding has been strongly supported by a 2022 paper published in the journal “Microorganisms”, which concludes sucralose consumption can induce gut dysbiosis (imbalance) and altered glucose and insulin levels in healthy young adults. ‘Concerningly, it’s not just saccharin and sucralose-based sweeteners that are under investigation. Two recent trials reported in “Nutrition Reviews” have shown that consumption of another popular sweetener, aspartame, may affect our body’s concentrations of glucose, insulin and a hormone that reduces appetite and releases insulin called “glucagon-like peptide 1”. ‘The root cause of some of these results is still being debated. Intriguing research published in the “Journal of Family Medicine and Primary Care” in 2020 investigated the possibility that ingestion of artificial sweeteners results in the erroneous release of insulin from the pancreas (due to their sweet taste). This increases the levels of insulin in our blood, eventually leading to decreased receptor activity due to insulin resistance. ‘Alarming discoveries like these latest artificial sweetener findings emphasize why Britain’s 4.3 million diabetics need regular, accurate blood testing. While “old school” traditional fingerprick tests using meters and strips are worthwhile, the next-gen “HbA1c” fingerprick tests are so sensitive that they could replace diabetics’ annual visits to their surgery for a full HbA1c blood test. ‘London Medical Laboratory’s fingerprick HbA1c “Diabetes – Diagnosis and Monitoring” test is considered the gold standard in regular testing. It is used to measure the average level of blood glucose over the past two to three months and both accurately monitor and diagnose diabetes. It can be taken at home through the post, or at one of the many drop-in clinics that offer these tests across London and nationwide in over 95 selected pharmacies and health stores. London Medical Laboratory

BBC headquarters is covered with blood red paint as controversy rages over corporation’s decision not to call baby-slaughtering Hamas ‘terrorists’ This comes just hours ahead of a planned march for a protest for Palestinians It set to start at Portland Place at 12pm before finishing in Whitehall at 3pm By Chloe Louise Published: 05:56 EDT, 14 October 2023 | Updated: 07:39 EDT, 14 October 2023